Sumitomo Pharma Co Ltd ADR SMDPY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $2.50
- Day Range
- $2.37–2.37
- 52-Week Range
- $2.33–3.29
- Bid/Ask
- $2.11 / $2.35
- Market Cap
- $941.58 Mil
- Volume/Avg
- 400 / 1,778
Key Statistics
- Price/Earnings (Normalized)
- 30.60
- Price/Sales
- 0.46
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 6,250
- Website
- https://www.sumitomo-pharma.com
Comparables
Valuation
|
Metric
|
SMDPY
|
4581
|
4554
|
|---|---|---|---|
Price/Earnings (Normalized) | 30.60 | 27.83 | 7.37 |
Price/Book Value | 0.96 | 0.84 | 0.84 |
Price/Sales | 0.46 | 2.17 | 0.86 |
Price/Cash Flow | — | 14.48 | 5.15 |
Price/Earnings
SMDPY
4581
4554
Financial Strength
|
Metric
|
SMDPY
|
4581
|
4554
|
|---|---|---|---|
Quick Ratio | 0.33 | 4.20 | 0.55 |
Current Ratio | 0.63 | 5.16 | 1.24 |
Interest Coverage | −55.06 | 68.75 | 58.74 |
Quick Ratio
SMDPY
4581
4554
Profitability
|
Metric
|
SMDPY
|
4581
|
4554
|
|---|---|---|---|
Return on Assets (Normalized) | −15.44% | 2.57% | 4.98% |
Return on Equity (Normalized) | −40.83% | 3.09% | 10.16% |
Return on Invested Capital (Normalized) | −24.50% | 2.64% | 6.17% |
Return on Assets
SMDPY
4581
4554
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Xxwlbrsxsw | Mycl | $79.1 Bil | |
MKKGY
| Merck KGaA ADR | Csgwkvgk | Cbcyqv | $74.3 Bil | |
HLN
| Haleon PLC ADR | Pprchsj | Mnk | $38.1 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Htvlwgpjv | Txfs | $19.1 Bil | |
VTRS
| Viatris Inc | Cmvfhtfk | Rcp | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Hcznfdly | Vtkf | $11.7 Bil | |
CTLT
| Catalent Inc | Pdvchdl | Ykdzvd | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Cvkblbgx | Kyd | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Yhdqzcx | Kpl | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Jxdgdwcj | Rwhlrw | $3.3 Bil |